MedPath

Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units

Completed
Conditions
Alzheimer Disease
Interventions
Behavioral: patients with alzheimer's disease
Registration Number
NCT01901263
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Cognitive and behavioral units (CBUs) have been created between 2008 and 2012 French National Alzheimer plan for the management of behavior problems of patients suffering from Alzheimer's disease or other related disorders and necessitating hospitalisation. This Alzheimer plan is promoting the evaluation of these units through the observation of the behavioral and psychological symptoms of dementia (BPSD) evolution. As these units are new, it appears important to assess their long-term impact on patients care.

Detailed Description

EXPECTED RESULTS The present study should allow to better understand the long-term impact of CBU on care of patients with Alzheimer disease and BPSD. Moreover, it should allow to identify patients improved by CBU.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
306
Inclusion Criteria
  • patient hospitalized on CBUs
  • patient with the diagnostic criteria for disease related to dementia stage with a Clinical Demential Rating β‰₯ 1
  • patient with a caregiver who is fairly frequent contact with the patient in order to observe the appearance of behavior changes
Exclusion Criteria
  • Patient living alone at home
  • Patient with risk of death within one year

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patient with alzheimer's diseasepatients with alzheimer's diseaseCohort of patients with psychological symptoms of dementia hospitalised in Cognitive and Behaviorial Units (CBUs) Evaluation of these units through the observation of the behavioral and psychological symptoms of dementia evolution : NPI score, caregivers quality of life, caregivers burden, collection of psychotropic drugs, the rehospitalisation rate
Primary Outcome Measures
NameTimeMethod
Neuropsychiatric Inventory (NPI) scoreone year

impact of CBU effectiveness in reducing BPSD

Secondary Outcome Measures
NameTimeMethod
Psychotropic drugs (in particular neuroleptic drugs) consumptionone year
rehospitalisation rate for BPSD of the patients in the year following their hospitalisation in CBUone year
CBU effectiveness in reducing BPSD6 months
CBU effectiveness on quality of life of patients and caregivers, and on caregivers' burdenone year

Trial Locations

Locations (3)

Hospices Civils de Lyon

πŸ‡«πŸ‡·

Villeurbanne, France

CHU de Saint Etienne

πŸ‡«πŸ‡·

Saint Etienne, France

CH Saint Jean de Dieu

πŸ‡«πŸ‡·

Lyon, France

Β© Copyright 2025. All Rights Reserved by MedPath